This inventor holds 1 USPTO granted patent. Top assignee: Unversität Zürich. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Susanne Sales: Innovator in Neurotrypsin Inhibition
Introduction
Susanne Sales is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of neurobiology, particularly in the area of neurotrypsin inhibition. Her innovative work has the potential to impact the treatment of various neurological disorders.
Latest Patents
Susanne Sales holds a patent for a method for determining inhibitors of neurotrypsin. This invention relates to a method for assessing whether a compound acts as a neurotrypsin inhibitor. The process involves incubating the compound with neurotrypsin and a protein or peptide comprising agrin in an aqueous buffer solution. The amount of cleavage of agrin is then measured. This method has led to the identification of inhibitors of neurotrypsin, which may be used for treating diseases caused by synaptic deficiencies, such as skeletal muscle atrophy, schizophrenia, and cognitive disturbances. She has 1 patent to her name.
Career Highlights
Susanne Sales is affiliated with the University of Zurich, where she conducts her research and develops her inventions. Her work is characterized by a strong focus on neurobiology and the mechanisms underlying synaptic function.
Collaborations
Throughout her career, Susanne has collaborated with notable colleagues, including Peter Sonderegger and Stefan Hettwer. These partnerships have enriched her research and contributed to her innovative approaches in the field.
Conclusion
Susanne Sales is a trailblazer in the realm of neurotrypsin inhibition, with her patented method offering promising avenues for medical advancements. Her contributions to neurobiology are invaluable and continue to inspire further research in the field.